Immunotech Laboratories, Inc. (Immunotech) is a drug development company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. Immunotech's key compound Immune Therapeutic Vaccine-1 (ITV-1) is a suspension of Inactivated Pepsin Fraction (IPF), which is for the treatment of human immunodeficiency virus/ acquired immune deficiency syndrome (HIV/AIDS) and Hepatitis C, and to modulate the immune system. The Company's other compounds in its pipeline include ITV-2 prenatal, ITV-3 Pediatric and ITV-4 HIV Vaccine. IPF is a platform technology that can be used to facilitate a range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals. IPF is the active drug substance of ITV-1 and is an extract of porcine pepsin.